At Pharmatech AI, we are thrilled to announce our strategic partnership with the International Intelligent Innovation Computing Center (IIICC). As a leading company in AI-driven drug discovery, specializing in nanomedicine, pain therapy, natural products, and cannabinoid research, we are committed to leveraging cutting-edge technologies to develop innovative therapies. This collaboration with IIICC, a pioneer in sustainable, Web3-based computing infrastructure, brings us significantly closer to achieving this goal.
Synergies for Innovative Research
This partnership combines our expertise in developing tailored AI solutions for the pharmaceutical industry with IIICC’s powerful, eco-friendly computing platform. IIICC’s super-compute clusters and open API ecosystem enable us to process complex datasets for cannabinoid research and other areas more efficiently. At the same time, IIICC’s renewable energy-based management supports our vision of establishing sustainable research processes.
A Look into the Future
With IIICC by our side, we can accelerate the development of novel therapies while reducing our environmental footprint. This partnership marks a milestone in pushing the boundaries of pharmaceutical innovation—from nanomedicine to pain therapy. Together, we are shaping a future where AI and sustainability go hand in hand to improve global health.Stay tuned for more updates on our projects!
Learn more about https://x.com/iiicc_ai